This content is current only at the time of printing. This document was printed on 3 August 2021. A current copy is located at https://apvma.gov.au/node/11551
You are here
Proposed approval of the new active constituent, Pigeon Paramyxovirus-1 Strain P201 (PPMV-1) and registration of Nobilis Paramyxo P201 Vaccine
This consultation closed on 26 August 2014.
The APVMA is considering an application for the registration of Nobilis Paramyxo P201 Vaccine and to approve the new active constituent, Pigeon Paramyxovirus-1 Strain P201 (PPMV-1). The product is to be registered for the active immunisation of pigeons 5 weeks old and above to reduce clinical signs caused by virulent PPMV-1 infection. The vaccine has also been shown to significantly reduce virus excretion after challenge.
We invite comment from 29 July 2014 to 26 August 2014 on whether the application for approval of the active constituent and registration of the product should be granted.
The APVMA is able to consider comments relating to the legislative grounds for registration, including:
- occupational health and safety
- safety and first aid
- chemistry and manufacture
- environmental fate and toxicity
For more information, see page 13 of Gazette No. 15 – 29 July 2014.
Please send your written submission by email, post or fax to:
Veterinary Medicines Program
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604
Fax: +61 2 6210 4721
For enquiries, please call +61 2 6210 4701.